あすか製薬ホールディングス(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4886/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2022/09/22日証協無担保1,300株+550%0株0%700株-69.57%
2022/09/22日証協有担保56,588株-32.48%14,374株+111.91%4,000株-63.3%
2022/09/16日証協無担保200株-99.38%0株0%2,300株+1038.61%
2022/09/16日証協有担保83,812株+104.98%6,783株+428.68%10,900株-83.36%
2022/09/09日証協無担保32,500株+1377.27%0株0%202株-93.04%
2022/09/09日証協有担保40,887株+198.08%1,283株+165.63%65,500株+371.19%
2022/09/02日証協無担保2,200株-91.3%0株0%2,902株+106.99%
2022/09/02日証協有担保13,717株-80.44%483株-62.35%13,901株-6.08%
2022/08/26日証協無担保25,300株+4960%0株0%1,402株-56.36%
2022/08/26日証協有担保70,117株-12.8%1,283株+156.6%14,801株-69.16%
2022/08/19日証協無担保500株0%0株0%3,213株+1444.71%
2022/08/19日証協有担保80,408株+64.83%500株+87.97%48,000株-29.71%
2022/08/12日証協無担保0株-100%0株0%208株-93.32%
2022/08/12日証協有担保48,783株+92.26%266株-96.3%68,284株+334.93%
2022/08/05日証協無担保1,500株+200%0株0%3,112株+63.36%
2022/08/05日証協有担保25,373株-6.03%7,183株0%15,700株-47.23%
2022/07/29日証協無担保500株+66.67%0株0%1,905株+532.89%
2022/07/29日証協有担保27,000株+92.03%0株-100%29,749株-7.57%
2022/07/22日証協無担保300株-98.65%0株0%301株-91.66%
2022/07/22日証協有担保14,060株+103.77%2株-99.99%32,184株-23%
2022/07/15日証協無担保22,300株+0.45%0株0%3,609株+259.46%
2022/07/15日証協有担保6,900株-30.3%16,702株+79.57%41,800株+12.06%
2022/07/08日証協無担保22,200株-65.37%0株0%1,004株-66.62%
2022/07/08日証協有担保9,900株-68.87%9,301株-30.6%37,300株-61.15%
2022/07/01日証協無担保64,100株+167.08%0株0%3,008株+25.33%
2022/07/01日証協有担保31,800株+2.54%13,402株+154.02%96,000株+91.24%
2022/06/24日証協無担保24,000株+458.14%0株0%2,400株-27.27%
2022/06/24日証協有担保31,012株+107.04%5,276株-80.82%50,200株+211.8%
2022/06/17日証協無担保4,300株+19.44%0株0%3,300株+312.5%
2022/06/17日証協有担保14,979株+9999.99%27,514株-23.63%16,100株+747.37%
2022/06/10日証協無担保3,600株0%0株0%800株-74.19%
2022/06/10日証協有担保24株-99.96%36,026株+313.47%1,900株-94.02%
2022/06/03日証協無担保0株-100%0株0%3,100株+72.22%
2022/06/03日証協有担保57,000株+442.86%8,713株-76.01%31,784株-53.33%
2022/05/27日証協無担保29,600株+3188.89%0株0%1,800株-31.17%
2022/05/27日証協有担保10,500株-51.39%36,326株+2.54%68,100株+389.93%
2022/05/20日証協無担保900株-18.18%0株0%2,615株+30.75%
2022/05/20日証協有担保21,600株+146.32%35,426株+8.92%13,900株+8.59%

※株式分割は考慮していませんのでご注意ください。

Page Top